methylphenidate hydrochloride
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
55 FDA-registered drug labelers
Accord Healthcare, Inc.
Actavis Pharma, Inc.
American Health Packaging
Amneal Pharmaceuticals of New York LLC
Ascend Laboratories, LLC
Aurolife Pharma, LLC
AvPAK
Aytu BioPharma, Inc.
Bryant Ranch Prepack
Camber Pharmaceutical Inc
Camber Pharmaceuticals Inc.
Cambrex Charles City, Inc
Catalent Pharma Solutions, LLC
Chattem Chemicals, Inc.
Cranbury Pharmaceuticals, LLC
Curia Missouri, Inc.
Dr. Reddy's Laboratories Inc
Eywa Pharma Inc
Golden State Medical Supply, Inc.
Granules Pharmaceuticals Inc.
Ironshore Pharmaceuticals Inc.
Janssen Pharmaceutical Sciences Unlimited Company
Janssen Pharmaceuticals, Inc.
KVK-TECH, INC.
Lannett Company, Inc.
Lupin Pharmaceuticals,Inc.
Mayne Pharma
Medisca Inc.
Neolpharma, Inc.
NextWave Pharmaceuticals, Inc
Nivagen Pharmaceuticals, Inc.
Noramco, LLC
Northstar Rx LLC
Novartis Pharmaceuticals Corporation
Patrin Pharma, Inc.
Professional Compounding Center of America
Professional Compounding Centers of America
QUAGEN PHARMACEUTICALS LLC
Rhodes Pharmaceuticals
Rhodes Pharmaceuticals L.P.
Rising Pharma Holdings, Inc.
S&B Pharma LLC dba Norac Pharma
Sandoz Inc
SHIONOGI INC.
Siegfried USA, LLC
Societal CDMO Gainesville, LLC
Solco Healthcare US,LLC
SpecGx LLC
Spectrum Laboratory Products, Inc.
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceuticals USA, Inc.
Trigen Laboratories, LLC
Veranova, L.P.
Vertical Pharmaceuticals, LLC
XLCare Pharmaceuticals Inc
Why It Matters
Sectors
Health
Downstream Uses
Appears in 16 drug and cosmetic product listings (FDA).
- •Methylphenidate Hydrochloride
- •Methylphenidate
- •Concerta
- •Relexxii
- •Methylphenidate Hydrochloride Extended-Release
- •Jornay PM Extended-Release
- •Methylphenidate Hydrochloride (LA)
- •QuilliChew ER
Show all 16
- •Aptensio XR
- •Metadate CD
- •methylphenidate hydrochloride CD
- •Ritalin
- •Quillivant XR
- •Ritalin LA
- •Methylphenidate HCl
- •Methylin
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Methylphenidate Hydrochloride Tablet, Extended Release
07/26/2023Unavailable
current
Methylphenidate Hydrochloride Tablet, Extended Release
07/26/2023Available
current
Methylphenidate Hydrochloride Tablet, Extended Release
07/26/2023Limited Availability
Chemical Identity
CAS298-59-9
PubChem CID9280
DTXSIDDTXSID8020886
FormulaC14H20ClNO2
Mol. Weight269.77 g/mol
SMILESCOC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl
Data Sources
92802026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/methylphenidate hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/methylphenidate hydrochloride.json
CAS 298-59-92026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 298-59-92026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json